Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/II study of ST-1898 tablets in advanced renal cell carcinoma
CTR20230114Phase 2Active
- Sponsor
- Beijing Scitech-MQ Pharmaceuticals Limited
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ACC-1898 in renal cell carcinoma (RCC), sponsored by Beijing Scitech-MQ Pharmaceuticals Limited. Started Mar 2023; status: active.
02
Drugs
ACC-1898
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on CTR20230114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230114.